“Or how about one of my absolute favorites right here too, AbbVie. Now here's a drug company with no patent cliff in sight whatsoever.
Keep Reading →
May 16 - Hedge Funds, News
“When interest rates go up, even if they go up just a little, you can see lots of very good well-known stocks with juicy dividends just get pummeled.
Keep Reading →
May 16 - Hedge Funds, News
Dividend-paying stocks have been gaining popularity among investors due to their long-term advantages.
Keep Reading →
May 13 - Dividend Stocks, Hedge Funds, News
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
Keep Reading →
May 12 - Hedge Funds, Industries, News
Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy.
Keep Reading →
May 10 - Dividend Stocks, Hedge Funds, News
We came across a bullish thesis on AbbVie Inc. (ABBV) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc.
Keep Reading →
May 7 - News, Stock Analysis
This article looks at ChatGPT Stock Advice: Top 12 Stock Recommendations.
Keep Reading →
May 5 - Hedge Funds, News
The healthcare industry, an essential component of global well-being and economic resilience, is undergoing significant changes.
Keep Reading →
April 26 - Business, Hedge Funds, News
Operator: Welcome to the AbbVie First Quarter 2025 Earnings Conference Call. All participants will be able to listen only until the question and answer portion of this call.
Keep Reading →
April 26 - News, Transcripts
Passive income, which refers to money earned with little ongoing effort, was once largely the domain of the wealthy – those who could afford to invest in rental properties or...
Keep Reading →
April 25 - Dividend Stocks, Hedge Funds, News
Value stocks are enjoying a rare period of strength amid this year’s broader market downturn.
Keep Reading →
April 23 - Dividend Stocks, Hedge Funds, News
Threats of an impending recession are looming over the stock market due to Trump's tariffs and macroeconomic uncertainty.
Keep Reading →
April 22 - Hedge Funds, News
On Thursday, Jim Cramer, the host of Mad Money, walked viewers through what he described as an important week ahead for Wall Street, with earnings season hitting full stride and...
Keep Reading →
April 20 - Hedge Funds, News
Goldman Sachs highlighted that equities around the world traded in and out of a bear market — which is often defined as a 20% decline from the recent peak.
Keep Reading →
April 17 - Hedge Funds, News
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.
Keep Reading →
April 16 - Hedge Funds, News
Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware of a lesser-known group called Dividend...
Keep Reading →
April 15 - Dividend Stocks, Hedge Funds, News
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
Keep Reading →
April 14 - Hedge Funds, News
Dividend stocks have trailed the broader market over the past two years, largely due to investors favoring AI-focused companies.
Keep Reading →
April 14 - Dividend Stocks, Hedge Funds, News
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” first quarter 2025 investor letter.
Keep Reading →
April 11 - Hedge Fund Investor Letters, News
Russell Investments believes that 3 features are defining the market outlook for 2025.
Keep Reading →
April 10 - Hedge Funds, News
Dividend Aristocrats are the companies that have raised their payouts for 25 consecutive years or more.
Keep Reading →
March 29 - Dividend Stocks, Hedge Funds, News
The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry.
Keep Reading →
March 20 - Dividend Stocks, Hedge Funds, News
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Keep Reading →
March 11 - Hedge Funds, Industries, News
Dividend stocks remain a popular choice among investors due to their ability to generate steady income.
Keep Reading →
March 9 - Dividend Stocks, Hedge Funds, News
Dividend stocks have taken a backseat in the market as technology and AI-driven equities have soared to record highs.
Keep Reading →
March 7 - Dividend Stocks, Hedge Funds, News
Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
March 4 - Hedge Fund Investor Letters, News
The stocks showcased initial enthusiasm post Trump’s election, as the S&P 500 saw an increase of 2.5% on the day after the November vote, says U.S. Bank.
Keep Reading →
March 3 - Hedge Funds, News
In contrast to drugs like cocaine or marijuana, psychedelics are strong and give users access to a kind of "alternate reality." One class of hallucinogenic substances that can...
Keep Reading →
February 28 - Hedge Funds, News
Stock market investors have enjoyed strong annual returns over the past two years, but analysts caution that 2025 may not deliver a repeat performance.
Keep Reading →
February 28 - Dividend Stocks, Hedge Funds, News
Dividend Aristocrats are companies that have consistently increased their dividend payments for at least 25 consecutive years.
Keep Reading →
February 24 - Dividend Stocks, Hedge Funds, News
Dividend investing is often regarded as a strategy that rewards patience, as it tends to generate stronger returns over the long term.
Keep Reading →
February 24 - Dividend Stocks, Hedge Funds, News
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.
Keep Reading →
February 16 - Hedge Funds, Industries, News
Lee Munder Capital Group Investments, more commonly known as LMCG Investments, LLC, is an independent, employee-owned investment management company.
Keep Reading →
February 13 - Hedge Funds, News
Jim Cramer, the host of Mad Money, on Tuesday, took a close look at President Donald Trump’s recent actions and his effect on the stock market, urging investors to pay closer...
Keep Reading →
February 5 - Hedge Funds, News
Cancer is the second leading cause of death across the globe, second to cardiovascular disease.
Keep Reading →
February 2 - Hedge Funds, News
Operator: Good morning and thank you for standing by. Welcome to the AbbVie Fourth Quarter 2024 Earnings Conference Call.
Keep Reading →
February 1 - News, Transcripts
AbbVie (ABBV), a large drug maker, is jumping 8% after the company provided significantly higher-than-expected 2025 earnings per share guidance this morning.
Keep Reading →
January 31 - Market Movers, News
On December 12, Tom Lee, Fundstrat Global Advisors managing partner and head of research, appeared on CNBC to talk about his 2025 playbook.
Keep Reading →
January 28 - Hedge Funds, News
As of January 2025, the prevailing sentiment among US economic experts leans towards cautious optimism regarding the stock market's trajectory.
Keep Reading →
January 24 - Hedge Funds, News
Halal stocks are shares in companies that adhere to Shariah law.
Keep Reading →
January 22 - Dividend Stocks, Hedge Funds, News
The market outlook is as uncertain as it gets.
Keep Reading →
January 21 - Hedge Funds, News
Dividend stocks, while popular among investors, have been underperforming for a while.
Keep Reading →
January 21 - Dividend Stocks, Hedge Funds, News
We came across a bullish thesis on AbbVie Inc. (ABBV) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on ABBV.
Keep Reading →
January 20 - News, Stock Analysis
Louis Navellier is a prominent American investor, author, and financial analyst, best known for his quantitative approach to stock selection and his long-standing track record...
Keep Reading →
January 18 - Hedge Funds, News
Investing in dividend stocks has been a focal point for investors for several years. The attractive income generated from these stocks motivates many to invest.
Keep Reading →
January 13 - Dividend Stocks, Hedge Funds, News
Macroeconomic factors have weighed on US stocks in the final days of the year, with the broader market declining by over 1% in the past week.
Keep Reading →
December 30 - Dividend Stocks, Hedge Funds, News
The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, reflecting a shift toward smaller, more strategic transactions...
Keep Reading →
December 30 - Dividend Stocks, Hedge Funds, News
To select stocks with long-term growth potential, investors should focus on fundamental analysis, evaluating financial health through earnings history, revenue growth, and profit...
Keep Reading →
December 30 - Hedge Funds, News
Dividend stocks had a challenging year in 2024 as investor interest largely shifted toward technology stocks.
Keep Reading →
December 29 - Dividend Stocks, Hedge Funds, News
Polaris Capital Management, an investment management company, released its third quarter 2024 investor letter. A copy of the same can be downloaded here.
Keep Reading →
December 23 - Hedge Fund Investor Letters, News